Cardiovascular Disease Clinical Trial
The mortality rate of treated patients with end stage renal disease(ESRD)is 22 deaths
patient-years at risk in 2006. Incident patients with ESRD are most vulnerable within the
first 90 days of dialysis, with an annualized mortality rate of 50 deaths/100 patient years.
The vast majority of these deaths are due to cardiovascular causes. As cardiac
rehabilitation programs have shown a 20% reduction in one year overall mortality rate post
myocardial infarction the investigator proposes that a similar type of rehabilitation
program will also have a benificial effect on morbidity and mortality in patients with
chronic kidney disease(CKD)and ESRD.The overall goal of this project is to study whether a
renal rehabilitation program based on guided exercise implemented in patients with stage III
and stage IV CKD can influence the mortality rate of these patients prior to and during the
first 90 days of dialysis
Hypothesis:The application of a guided exercise program (renal rehabilitation) instituted in
patients with stage III or Stage IV CKD will decrease the mortality rate prior to the
initiation of renal replacement therapy.
Hypothesis:The application of renal rehabilitation during the late stages of CKD will
decrease the mortality risk during the first 90 days of renal rehabilitation therapy.
Hypothesis:A guided exercise program will have an immediate and prolonged effect on activity
levels, mental health and adaption to chronic illness in patients with advanced CKD.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02122198 -
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
|
N/A | |
| Completed |
NCT02502812 -
Bioequivalence Study of Clopidogrel 75 mg in Two Tablet Formulations Relative to Reference Tablet in Healthy Subjects
|
Phase 1 | |
| Recruiting |
NCT04216342 -
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fx-5A in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT03654313 -
Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes Mellitus
|
Phase 1 | |
| Completed |
NCT03646656 -
Heart Health Buddies: Peer Support to Decrease CVD Risk
|
N/A | |
| Completed |
NCT02081066 -
Identification of CETP as a Marker of Atherosclerosis
|
N/A | |
| Completed |
NCT02147626 -
Heart Health 4 Moms Trial to Reduce CVD Risk After Preeclampsia
|
N/A | |
| Not yet recruiting |
NCT06405880 -
Pharmacist Case Finding and Intervention for Vascular Prevention Trial
|
N/A | |
| Recruiting |
NCT03095261 -
Incentives in Cardiac Rehabilitation
|
N/A | |
| Completed |
NCT02868710 -
Individual Variability to Aerobic Exercise Training
|
N/A | |
| Completed |
NCT02589769 -
Effects of Reduction in Saturated Fat on Cholesterol and Lipoproteins in Lean and Obese Persons
|
N/A | |
| Completed |
NCT02998918 -
Effects of Short-term Curcumin and Multi-polyphenol Supplementation on the Anti-inflammatory Properties of HDL
|
N/A | |
| Not yet recruiting |
NCT02578355 -
National Plaque Registry and Database
|
N/A | |
| Completed |
NCT02711878 -
Healing Hearts and Mending Minds in Older Adults Living With HIV
|
N/A | |
| Recruiting |
NCT02885792 -
Coronary Artery Disease in Patients Suffering From Schizophrenia
|
N/A | |
| Completed |
NCT02272946 -
Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk
|
Phase 2 | |
| Completed |
NCT02657382 -
Mental Stress Ischemia: Biofeedback Study
|
N/A | |
| Completed |
NCT02652975 -
Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium
|
N/A | |
| Completed |
NCT02640859 -
Investigation of Metabolic Risk in Korean Adults
|
||
| Recruiting |
NCT02265250 -
Pilot Study-Magnetic Resonance Imaging for Global Atherosclerosis Risk Assessment
|